PLRX
NASDAQ · Pharmaceuticals
Pliant Therapeutics Inc
$1.04
-0.01 (-0.95%)
Open$1.05
Previous Close$1.05
Day High$1.06
Day Low$1.03
52W High$1.95
52W Low$1.03
Volume—
Avg Volume282.6K
Market Cap65.02M
P/E Ratio—
EPS$-2.43
SectorPharmaceuticals
Analyst Ratings
Strong Sell
10 analysts
Price Target
+1,542.3% upside
Current
$1.04
$1.04
Target
$17.08
$17.08
$13.48
$17.08 avg
$25.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.16M | 13.79M | 14.54M |
| Net Income | 3.08M | 2.65M | 3.08M |
| Profit Margin | 20.3% | 19.2% | 21.2% |
| EBITDA | 5.59M | 4.59M | 4.96M |
| Free Cash Flow | 2.06M | 2.45M | 2.36M |
| Rev Growth | +19.0% | -9.0% | -2.1% |
| Debt/Equity | 0.34 | 0.31 | 0.34 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |